US Stem Cell Inc (USRM)

[Dragon Lady]

"The market is pricing this company based on the financials "? As nearly ALL companies are priced/valued- "earnings" being the number one determiner of price across the entire stock market, top line sales growth probably number 2, or customer acquired massive growth (eyeballs - like a Facebook for example- but numbers must be huge, as in staggering enormous and rapid, rapid, growth) then dividends paid out, then perhaps cash on hand- as in an R&D company but they must have yrs of "burn rate" cash on the books and little to no debt typically and extremely strong mgt with track records of past success, etc.

When did that ever change?

And "loans"? Companies with no cash flow, no sales, no revenues, no profits, no assets for the most part, etc are almost never, ever candidates for "loans"- unless someone else, something else is willing to put up what is known as "collateral" and/or security for said loan (a debt instrument).

That's my opinion for course- but backed by lots of stock market, well reported facts from credible source like CNBC or similar, academia statistics, etc from major agencies, funds, research companies etc.